IBDEI1LR ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26813,1,3,0)
 ;;=3^Zoster (Shingles) Vaccine
 ;;^UTILITY(U,$J,358.3,26814,0)
 ;;=B18.2^^132^1304^26
 ;;^UTILITY(U,$J,358.3,26814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26814,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,26814,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,26814,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,26815,0)
 ;;=C44.99^^132^1304^50
 ;;^UTILITY(U,$J,358.3,26815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26815,1,3,0)
 ;;=3^Skin Cancer,Unspec
 ;;^UTILITY(U,$J,358.3,26815,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,26815,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,26816,0)
 ;;=E11.9^^132^1304^15
 ;;^UTILITY(U,$J,358.3,26816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26816,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,26816,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,26816,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,26817,0)
 ;;=E11.40^^132^1304^16
 ;;^UTILITY(U,$J,358.3,26817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26817,1,3,0)
 ;;=3^Diabetes Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,26817,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,26817,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,26818,0)
 ;;=E78.2^^132^1304^27
 ;;^UTILITY(U,$J,358.3,26818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26818,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,26818,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,26818,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,26819,0)
 ;;=E78.5^^132^1304^28
 ;;^UTILITY(U,$J,358.3,26819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26819,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,26819,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,26819,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,26820,0)
 ;;=E66.3^^132^1304^44
 ;;^UTILITY(U,$J,358.3,26820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26820,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,26820,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,26820,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,26821,0)
 ;;=D64.9^^132^1304^3
 ;;^UTILITY(U,$J,358.3,26821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26821,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,26821,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,26821,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,26822,0)
 ;;=F17.200^^132^1304^41
 ;;^UTILITY(U,$J,358.3,26822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26822,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,26822,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,26822,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,26823,0)
 ;;=F17.229^^132^1304^38
 ;;^UTILITY(U,$J,358.3,26823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26823,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco
 ;;^UTILITY(U,$J,358.3,26823,1,4,0)
 ;;=4^F17.229
 ;;^UTILITY(U,$J,358.3,26823,2)
 ;;=^5003374
 ;;^UTILITY(U,$J,358.3,26824,0)
 ;;=F19.10^^132^1304^53
 ;;^UTILITY(U,$J,358.3,26824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26824,1,3,0)
 ;;=3^Substance Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,26824,1,4,0)
 ;;=4^F19.10
 ;;^UTILITY(U,$J,358.3,26824,2)
 ;;=^5003416
 ;;^UTILITY(U,$J,358.3,26825,0)
 ;;=F15.10^^132^1304^52
 ;;^UTILITY(U,$J,358.3,26825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26825,1,3,0)
 ;;=3^Stimulant Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,26825,1,4,0)
 ;;=4^F15.10
 ;;^UTILITY(U,$J,358.3,26825,2)
 ;;=^5003282
 ;;^UTILITY(U,$J,358.3,26826,0)
 ;;=F43.21^^132^1304^2
 ;;^UTILITY(U,$J,358.3,26826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26826,1,3,0)
 ;;=3^Adjustment d/o w/ Depressed Mood
 ;;^UTILITY(U,$J,358.3,26826,1,4,0)
 ;;=4^F43.21
 ;;^UTILITY(U,$J,358.3,26826,2)
 ;;=^331948
 ;;^UTILITY(U,$J,358.3,26827,0)
 ;;=G43.909^^132^1304^37
